Coronavirus Vaccine Registration: On Sunday, India's drugs regulator, Drugs Controller General of India (DCGI) had approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Now, millions of people in India want to know what all documents are required for registrations of eligible beneficiary for COVID19 vaccination. Modi government has provided a FULL LIST of documents required for Covid-19 vaccination. Here is FULL LIST of documents required for Coronavirus Vaccine Registration:

The Drugs Controller General of India (DCGI) granted the approval on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). "After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situations," DCGI Dr V G Somani told the media. "Serum and Bharat Biotech vaccines have to be administered in two doses. All the three vaccines have to be stored at 2-8 C," he said.

This paves the way for the roll out of at least two vaccines in India in the coming days.

The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield, while Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Prime Minister Narendra Modi termed the approval a decisive turning point in India's fight against coronavirus. "DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators," he tweeted. "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion," he said in another tweet. He also saluted the frontline workers who have been leading the country's fight against the virus.

Serum Institute of India's CEO Adar Poonawalla tweeted, "COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks." In his media statement, Somani also said Cadila Healthcare has been granted the permission to conduct the Phase III clinical trial of its vaccine candidate in India.

Pune-based SII's shot is a Recombinant Chimpanzee Adenovirus vector vaccine (Covishield), encoding the SARS-CoV-2 Spike (S) glycoprotein with technology transfer from AstraZeneca/Oxford University.